Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sullivan

Showing results (911-920 of 1,277) with videos related to

Pageof 128
Sort By:
Current Developments in Nutrition|September 2, 2025
Enteral High-Dose Docosahexaenoic Acid and Neurodevelopment in Extremely Preterm Infants: A Systematic Review and Meta-analysisEmily Shepherd, Naho Ikeda, Thomas R Sullivan, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Depression symptom trends and health domains among lung cancer patients in the CanCORS studyD R Sullivan, C W Forsberg, L Ganzini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2016
Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et alN I Cherny, R Sullivan, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2016
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)N I Cherny, R Sullivan, U Dafni, et al.
Diabetes Research and Clinical Practice|July 1, 1990
The effects of dietary n - 3 fatty acid in animal models of type 1 and type 2 diabetesD R Sullivan, D K Yue, C Capogreco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2020
Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et alN I Cherny, R Sullivan, U Dafni, et al.
The Journal of Infection|January 19, 2024
Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia 2017-2020Mark McMillan, Hassen Mohammed, Jana Bednarz, et al.
Translational Psychiatry|September 24, 2022
For whom the bell tolls: psychopathological and neurobiological correlates of a DNA methylation index of time-to-deathSage E Hawn, Xiang Zhao, Danielle R Sullivan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1978
Isopropylbiphenyl metabolism in the rat. Relationships between metabolism, pharmacology and toxicologyH R Sullivan, R E McMahon, P Roffey, et al.
Nutrients|May 12, 2017
The Effect of Dietary Glycemic Properties on Markers of Inflammation, Insulin Resistance, and Body Composition in Postmenopausal American Women: An Ancillary Study from a Multicenter Protein Supplementation TrialVioleta Stojkovic, Christine A Simpson, Rebecca R Sullivan, et al.
Pageof 128

Showing results (911-920 of 1,277) with videos related to

Sort By:
Pageof 128
Current Developments in Nutrition|September 2, 2025
Enteral High-Dose Docosahexaenoic Acid and Neurodevelopment in Extremely Preterm Infants: A Systematic Review and Meta-analysisEmily Shepherd, Naho Ikeda, Thomas R Sullivan, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Depression symptom trends and health domains among lung cancer patients in the CanCORS studyD R Sullivan, C W Forsberg, L Ganzini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2016
Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et alN I Cherny, R Sullivan, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2016
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)N I Cherny, R Sullivan, U Dafni, et al.
Diabetes Research and Clinical Practice|July 1, 1990
The effects of dietary n - 3 fatty acid in animal models of type 1 and type 2 diabetesD R Sullivan, D K Yue, C Capogreco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2020
Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et alN I Cherny, R Sullivan, U Dafni, et al.
The Journal of Infection|January 19, 2024
Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia 2017-2020Mark McMillan, Hassen Mohammed, Jana Bednarz, et al.
Translational Psychiatry|September 24, 2022
For whom the bell tolls: psychopathological and neurobiological correlates of a DNA methylation index of time-to-deathSage E Hawn, Xiang Zhao, Danielle R Sullivan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1978
Isopropylbiphenyl metabolism in the rat. Relationships between metabolism, pharmacology and toxicologyH R Sullivan, R E McMahon, P Roffey, et al.
Nutrients|May 12, 2017
The Effect of Dietary Glycemic Properties on Markers of Inflammation, Insulin Resistance, and Body Composition in Postmenopausal American Women: An Ancillary Study from a Multicenter Protein Supplementation TrialVioleta Stojkovic, Christine A Simpson, Rebecca R Sullivan, et al.
Pageof 128